"Bristol-Myers Squibb" - Google News

Bristol Myers Squibb turns to China to develop new drugs in newest cross-continent collaboration - CNBC

Fri, 15 May 2026 15:04:15 GMT

Bristol Myers Squibb turns to China to develop new drugs in newest cross-continent collaboration CNBC

Another pharma giant eyes Houston for $1B plant with hundreds of jobs possible - KHOU

Fri, 15 May 2026 19:28:00 GMT

Another pharma giant eyes Houston for $1B plant with hundreds of jobs possible KHOU

Bristol Myers Squibb considering building $1B pharma plant in Houston - Houston Chronicle

Sat, 16 May 2026 21:30:23 GMT

Bristol Myers Squibb considering building $1B pharma plant in Houston Houston Chronicle

Bristol Myers Squibb eyes Houston for $1B pharmaceutical plant - The Business Journals

Fri, 15 May 2026 19:03:00 GMT

Bristol Myers Squibb eyes Houston for $1B pharmaceutical plant The Business Journals

American Factories Lag in Adopting A.I. This Drugmaker Is an Exception. - The New York Times

Wed, 06 May 2026 07:00:00 GMT

American Factories Lag in Adopting A.I. This Drugmaker Is an Exception. The New York Times

China's Hengrui, Bristol Myers Squibb sign collaboration, licensing deals - Reuters

Tue, 12 May 2026 10:22:56 GMT

China's Hengrui, Bristol Myers Squibb sign collaboration, licensing deals Reuters

Bristol Myers Squibb partners with China’s Hengrui Pharma on a dozen drugs - statnews.com

Tue, 12 May 2026 07:48:54 GMT

Bristol Myers Squibb partners with China’s Hengrui Pharma on a dozen drugs statnews.com

Is Hengrui’s US$15.2 Billion Alliance Reshaping the Investment Case for Bristol Myers Squibb (BMY)? - simplywall.st

Sat, 16 May 2026 11:53:26 GMT

Is Hengrui’s US$15.2 Billion Alliance Reshaping the Investment Case for Bristol Myers Squibb (BMY)? simplywall.st

Bristol-Myers Squibb and China’s Hengrui Pharma Forge Tie-Up - WSJ

Tue, 12 May 2026 06:35:00 GMT

Bristol-Myers Squibb and China’s Hengrui Pharma Forge Tie-Up WSJ

DNB Asset Management AS Boosts Holdings in Bristol Myers Squibb Company $BMY - MarketBeat

Sat, 16 May 2026 09:33:04 GMT

DNB Asset Management AS Boosts Holdings in Bristol Myers Squibb Company $BMY MarketBeat

BMS inks $15B deal to bag Hengrui assets, tap China’s R&D speed - Fierce Biotech

Tue, 12 May 2026 05:56:39 GMT

BMS inks $15B deal to bag Hengrui assets, tap China’s R&D speed Fierce Biotech

Tigerlily Foundation Collaborates with Bristol Myers Squibb to Advance Clinical Trial Access and Equity - PR Newswire

Fri, 15 May 2026 13:24:00 GMT

Tigerlily Foundation Collaborates with Bristol Myers Squibb to Advance Clinical Trial Access and Equity PR Newswire

A Look At Bristol Myers Squibb (BMY) Valuation After Major Hengrui Collaboration Announcement - Yahoo Finance

Fri, 15 May 2026 09:15:30 GMT

A Look At Bristol Myers Squibb (BMY) Valuation After Major Hengrui Collaboration Announcement Yahoo Finance

Bristol Myers Squibb inks $15.2B drug deal with Hengrui - NJBIZ

Tue, 12 May 2026 18:50:31 GMT

Bristol Myers Squibb inks $15.2B drug deal with Hengrui NJBIZ

Bristol Myers Squibb signs billion-dollar deal with Chinese company for 13 projects - medwatch.com

Fri, 15 May 2026 08:01:51 GMT

Bristol Myers Squibb signs billion-dollar deal with Chinese company for 13 projects medwatch.com

Rx Rundown: Bristol Myers Squibb, Isomorphic Labs, Partner Therapeutics and more - Medical Marketing and Media

Fri, 15 May 2026 12:02:39 GMT

Rx Rundown: Bristol Myers Squibb, Isomorphic Labs, Partner Therapeutics and more Medical Marketing and Media

BMS, Hengrui build 13-asset pipeline in $15B+ onco-immune deal - BioSpace

Tue, 12 May 2026 12:24:22 GMT

BMS, Hengrui build 13-asset pipeline in $15B+ onco-immune deal BioSpace

Tempus AI Stock (TEM) Opinions on Bristol Myers Squibb Partnership Expansion - Quiver Quantitative

Thu, 14 May 2026 17:42:00 GMT

Tempus AI Stock (TEM) Opinions on Bristol Myers Squibb Partnership Expansion Quiver Quantitative

Bristol Myers Squibb Launches “Won't Lose” Media Campaign Ahead of FIFA World Cup 2026 - Bristol Myers Squibb

Mon, 04 May 2026 07:00:00 GMT

Bristol Myers Squibb Launches “Won't Lose” Media Campaign Ahead of FIFA World Cup 2026 Bristol Myers Squibb

Bristol-Myers Squibb (BMY): Buy, Sell, or Hold Post Q1 Earnings? - Yahoo Finance

Thu, 14 May 2026 19:56:55 GMT

Bristol-Myers Squibb (BMY): Buy, Sell, or Hold Post Q1 Earnings? Yahoo Finance

Bristol Myers Squibb Hengrui Deal Expands Pipeline And Valuation Upside Potential - simplywall.st

Thu, 14 May 2026 19:45:18 GMT

Bristol Myers Squibb Hengrui Deal Expands Pipeline And Valuation Upside Potential simplywall.st

Tempus Expands Strategic Collaboration with Bristol Myers Squibb to Enhance the Probability of Success Across Clinical Development Programs In Oncology and Neuroscience - Business Wire

Thu, 14 May 2026 12:30:00 GMT

Tempus Expands Strategic Collaboration with Bristol Myers Squibb to Enhance the Probability of Success Across Clinical Development Programs In Oncology and Neuroscience Business Wire

Bristol Myers Squibb Expands Pipeline With Hengrui Multi Billion Drug Alliance - Yahoo Finance

Tue, 12 May 2026 11:15:42 GMT

Bristol Myers Squibb Expands Pipeline With Hengrui Multi Billion Drug Alliance Yahoo Finance

Is Bristol Myers Squibb Stock Overvalued at Nearly $60? A Reality Check for Value Investors. - The Motley Fool

Tue, 12 May 2026 02:15:00 GMT

Is Bristol Myers Squibb Stock Overvalued at Nearly $60? A Reality Check for Value Investors. The Motley Fool

Bristol Myers Squibb signs $15.2B licensing deal with Hengrui - qz.com

Tue, 12 May 2026 13:50:53 GMT

Bristol Myers Squibb signs $15.2B licensing deal with Hengrui qz.com

Bristol Myers Squibb Company $BMY Shares Sold by Trek Financial LLC - MarketBeat

Thu, 14 May 2026 09:17:12 GMT

Bristol Myers Squibb Company $BMY Shares Sold by Trek Financial LLC MarketBeat

Bristol Myers Squibb Logs Higher Sales, Profit - WSJ

Thu, 30 Apr 2026 07:00:00 GMT

Bristol Myers Squibb Logs Higher Sales, Profit WSJ

Bristol Myers Squibb and Hengrui Forge $15.2 Billion Strategic Alliance, Reshaping China-Out Licensing Landscape - Oncodaily

Fri, 15 May 2026 15:44:17 GMT

Bristol Myers Squibb and Hengrui Forge $15.2 Billion Strategic Alliance, Reshaping China-Out Licensing Landscape Oncodaily

Michael Pourdehnad: New Strategic Collaboration between Bristol Myers Squibb and Hengrui Pharma Reflects a Shared Commitment - Oncodaily

Thu, 14 May 2026 01:47:28 GMT

Michael Pourdehnad: New Strategic Collaboration between Bristol Myers Squibb and Hengrui Pharma Reflects a Shared Commitment Oncodaily

Bristol Myers Squibb (BMY) Valuation Check After Recent Share Weakness And Mixed 2024 Earnings - simplywall.st

Tue, 12 May 2026 18:51:47 GMT

Bristol Myers Squibb (BMY) Valuation Check After Recent Share Weakness And Mixed 2024 Earnings simplywall.st

Bristol Myers Squibb Company $BMY Holdings Decreased by Conning Inc. - MarketBeat

Fri, 15 May 2026 08:33:39 GMT

Bristol Myers Squibb Company $BMY Holdings Decreased by Conning Inc. MarketBeat

AustralianSuper Pty Ltd Decreases Stock Holdings in Bristol Myers Squibb Company $BMY - MarketBeat

Fri, 15 May 2026 07:52:20 GMT

AustralianSuper Pty Ltd Decreases Stock Holdings in Bristol Myers Squibb Company $BMY MarketBeat

Bristol Myers Squibb: The CAR-T Giant The Market Is Undervaluing (NYSE:BMY) - Seeking Alpha

Sat, 02 May 2026 07:00:00 GMT

Bristol Myers Squibb: The CAR-T Giant The Market Is Undervaluing (NYSE:BMY) Seeking Alpha

Tempus AI, Bristol Myers Squibb Expand AI-Driven Clinical Trial Efforts - Benzinga

Thu, 14 May 2026 18:23:23 GMT

Tempus AI, Bristol Myers Squibb Expand AI-Driven Clinical Trial Efforts Benzinga

Bristol Myers, Hengrui Pharma Team Up in Global Drug Research Pact That Could Top $15B - MedCity News

Tue, 12 May 2026 18:40:40 GMT

Bristol Myers, Hengrui Pharma Team Up in Global Drug Research Pact That Could Top $15B MedCity News

Bristol-Myers Squibb Company Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next - Yahoo Finance

Sun, 03 May 2026 07:00:00 GMT

Bristol-Myers Squibb Company Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next Yahoo Finance

Bristol Myers Squibb And Hengrui Pharma Enter $15.2 Billion Global Collaboration To Advance 13 Early‑Stage Programs - Pulse 2.0

Wed, 13 May 2026 12:04:11 GMT

Bristol Myers Squibb And Hengrui Pharma Enter $15.2 Billion Global Collaboration To Advance 13 Early‑Stage Programs Pulse 2.0

Bernstein reiterates Bristol-Myers Squibb stock rating on China deal - Investing.com

Wed, 13 May 2026 12:58:27 GMT

Bernstein reiterates Bristol-Myers Squibb stock rating on China deal Investing.com

Bristol Myers Squibb Company $BMY Shares Sold by Bank Julius Baer & Co. Ltd Zurich - MarketBeat

Thu, 14 May 2026 08:30:09 GMT

Bristol Myers Squibb Company $BMY Shares Sold by Bank Julius Baer & Co. Ltd Zurich MarketBeat

Bristol Myers Squibb Strikes $15.2 Billion Drug Development Deal With Hengrui Pharma - Benzinga

Tue, 12 May 2026 09:46:12 GMT

Bristol Myers Squibb Strikes $15.2 Billion Drug Development Deal With Hengrui Pharma Benzinga

Fierce Pharma Asia—BMS-Hengrui's $15B deal; Takeda’s 4.5K layoffs; Daiichi’s oncology ambition - Fierce Pharma

Fri, 15 May 2026 12:30:00 GMT

Fierce Pharma Asia—BMS-Hengrui's $15B deal; Takeda’s 4.5K layoffs; Daiichi’s oncology ambition Fierce Pharma

BMO reiterates Bristol-Myers Squibb stock rating on Hengrui deal - Investing.com

Tue, 12 May 2026 15:27:50 GMT

BMO reiterates Bristol-Myers Squibb stock rating on Hengrui deal Investing.com

Bristol-Myers Squibb shares fell for seventh consecutive session - MSN

Tue, 12 May 2026 03:57:16 GMT

Bristol-Myers Squibb shares fell for seventh consecutive session MSN

BMS, Hengrui Pharma Partner on 13 Programs in Up-to-$15.2B Collaboration - Genetic Engineering and Biotechnology News

Wed, 13 May 2026 20:34:52 GMT

BMS, Hengrui Pharma Partner on 13 Programs in Up-to-$15.2B Collaboration Genetic Engineering and Biotechnology News

Is Bristol Myers Squibb Stock Overvalued at Nearly $60? A Reality Check for Value Investors. - AOL.com

Tue, 12 May 2026 01:52:57 GMT

Is Bristol Myers Squibb Stock Overvalued at Nearly $60? A Reality Check for Value Investors. AOL.com

Bristol-Myers Squibb Company stock (US0897961004): multi?billion Hengrui deal reshapes oncology pipe - AD HOC NEWS

Sat, 16 May 2026 13:56:45 GMT

Bristol-Myers Squibb Company stock (US0897961004): multi?billion Hengrui deal reshapes oncology pipe AD HOC NEWS

Biopharma Collaboration: Bristol Myers Squibb Partners with Heng - GuruFocus

Fri, 15 May 2026 16:36:22 GMT

Biopharma Collaboration: Bristol Myers Squibb Partners with Heng GuruFocus

Q2 EPS Forecast for Bristol Myers Squibb Lowered by Analyst - MarketBeat

Fri, 15 May 2026 12:15:32 GMT

Q2 EPS Forecast for Bristol Myers Squibb Lowered by Analyst MarketBeat

BMS teams up with Tempus to see if AI can improve clinical success - FirstWord Pharma

Thu, 14 May 2026 21:33:44 GMT

BMS teams up with Tempus to see if AI can improve clinical success FirstWord Pharma

Is Bristol Myers Squibb the Best Bargain in Big Pharma? - Yahoo Finance

Mon, 27 Apr 2026 07:00:00 GMT

Is Bristol Myers Squibb the Best Bargain in Big Pharma? Yahoo Finance

$600m upfront, $15.2bn on the table: Hengrui and BMS forge deal across 13 programs - BioXconomy

Wed, 13 May 2026 09:12:13 GMT

$600m upfront, $15.2bn on the table: Hengrui and BMS forge deal across 13 programs BioXconomy

Tempus broadens collaboration with BMS for clinical trials - Clinical Trials Arena

Fri, 15 May 2026 11:19:08 GMT

Tempus broadens collaboration with BMS for clinical trials Clinical Trials Arena

Bristol Myers Squibb Cutting 206 More Jobs - New Jersey Business Magazine

Wed, 22 Apr 2026 07:00:00 GMT

Bristol Myers Squibb Cutting 206 More Jobs New Jersey Business Magazine

Champions in Care - Bristol Myers Squibb

Sun, 14 Dec 2025 08:00:00 GMT

Champions in Care Bristol Myers Squibb

The Time Back campaign honors the most precious gift oncologists provide in cancer care: time - Bristol Myers Squibb

Wed, 11 Mar 2026 07:00:00 GMT

The Time Back campaign honors the most precious gift oncologists provide in cancer care: time Bristol Myers Squibb

BMS and Hengrui Partner on 13 Oncology, Hematology, and Immunology Programs in Deal Worth Potentially $15.2 Billion - BioPharm International

Tue, 12 May 2026 15:32:31 GMT

BMS and Hengrui Partner on 13 Oncology, Hematology, and Immunology Programs in Deal Worth Potentially $15.2 Billion BioPharm International

Bristol Myers beats quarterly profit estimates on blood thinner, cancer drug sales - Reuters

Thu, 30 Apr 2026 07:00:00 GMT

Bristol Myers beats quarterly profit estimates on blood thinner, cancer drug sales Reuters

Bristol Myers Squibb and Hengrui Pharma sign major licencing deal - FinanceAsia

Wed, 13 May 2026 00:48:08 GMT

Bristol Myers Squibb and Hengrui Pharma sign major licencing deal FinanceAsia

Bristol-Myers Squibb: 'Strong Buy' As 2026 Milestones Could Bolster Its Prospects (NYSE:BMY) - Seeking Alpha

Mon, 27 Apr 2026 07:00:00 GMT

Bristol-Myers Squibb: 'Strong Buy' As 2026 Milestones Could Bolster Its Prospects (NYSE:BMY) Seeking Alpha

Bristol Myers Reports Surprise Sales Growth, But There's A Caveat - Investor's Business Daily

Thu, 30 Apr 2026 07:00:00 GMT

Bristol Myers Reports Surprise Sales Growth, But There's A Caveat Investor's Business Daily

Bristol Myers, Hengrui join forces in drugmaking alliance worth up to $15.2 billion - Yahoo Finance

Tue, 12 May 2026 08:18:00 GMT

Bristol Myers, Hengrui join forces in drugmaking alliance worth up to $15.2 billion Yahoo Finance

Vital Signs: BMS outsources its outsourcing - FirstWord Pharma

Wed, 13 May 2026 02:03:59 GMT

Vital Signs: BMS outsources its outsourcing FirstWord Pharma

Why Bristol Myers Squibb Stock Rocked the Market Today - The Motley Fool

Thu, 30 Apr 2026 07:00:00 GMT

Why Bristol Myers Squibb Stock Rocked the Market Today The Motley Fool

Bristol Myers and China’s Hengrui Pharma ink a licensing deal worth up to $15.2B - Seeking Alpha

Tue, 12 May 2026 12:03:25 GMT

Bristol Myers and China’s Hengrui Pharma ink a licensing deal worth up to $15.2B Seeking Alpha

BMS and Hengrui forge $15.2bn alliance for early-stage drugs - Pharmaceutical Technology

Tue, 12 May 2026 18:53:06 GMT

BMS and Hengrui forge $15.2bn alliance for early-stage drugs Pharmaceutical Technology

Bristol-Myers Squibb Precision Oncology Deal Meets Mixed Valuation Signals - Yahoo Finance

Sat, 25 Apr 2026 07:00:00 GMT

Bristol-Myers Squibb Precision Oncology Deal Meets Mixed Valuation Signals Yahoo Finance

AI in pharma marketing: Lessons from Bristol Myers Squibb - Adobe for Business

Mon, 20 Apr 2026 07:00:00 GMT

AI in pharma marketing: Lessons from Bristol Myers Squibb Adobe for Business

Bristol Myers Squibb (BMY) Partners with Hengrui Pharma for $15. - GuruFocus

Tue, 12 May 2026 14:44:07 GMT

Bristol Myers Squibb (BMY) Partners with Hengrui Pharma for $15. GuruFocus

Coordinating global clinical trials to advance medicines through PDS - Bristol Myers Squibb

Thu, 26 Mar 2026 07:00:00 GMT

Coordinating global clinical trials to advance medicines through PDS Bristol Myers Squibb

Bristol-Myers Squibb Company (BMY): Favorite for Conservative Portfolios - Yahoo Finance

Fri, 24 Apr 2026 07:00:00 GMT

Bristol-Myers Squibb Company (BMY): Favorite for Conservative Portfolios Yahoo Finance

Can Bristol Myers Squibb’s pipeline strategy offset a major patent cliff? - Labiotech.eu

Mon, 27 Apr 2026 07:00:00 GMT

Can Bristol Myers Squibb’s pipeline strategy offset a major patent cliff? Labiotech.eu

Redefining biologics & cell therapy manufacturing at Devens - Bristol Myers Squibb

Fri, 23 Jan 2026 08:00:00 GMT

Redefining biologics & cell therapy manufacturing at Devens Bristol Myers Squibb

Bristol Myers’ legacy lift, Biogen’s blue skies and Regeneron’s murky outlook - BioPharma Dive

Fri, 01 May 2026 07:00:00 GMT

Bristol Myers’ legacy lift, Biogen’s blue skies and Regeneron’s murky outlook BioPharma Dive

BMS signs $15.2bn R&D alliance with China's Hengrui - pharmaphorum

Wed, 13 May 2026 16:59:18 GMT

BMS signs $15.2bn R&D alliance with China's Hengrui pharmaphorum

Bristol Myers, Pfizer to offer blockbuster blood thinner through Mark Cuban's online pharmacy - Reuters

Fri, 24 Apr 2026 07:00:00 GMT

Bristol Myers, Pfizer to offer blockbuster blood thinner through Mark Cuban's online pharmacy Reuters

Bristol Myers Squibb Pipeline Update With New TYK2 And CELMoD Milestones - Yahoo Finance

Tue, 10 Mar 2026 07:00:00 GMT

Bristol Myers Squibb Pipeline Update With New TYK2 And CELMoD Milestones Yahoo Finance

Securian Asset Management Inc. Reduces Position in Bristol Myers Squibb Company $BMY - MarketBeat

Mon, 11 May 2026 10:37:49 GMT

Securian Asset Management Inc. Reduces Position in Bristol Myers Squibb Company $BMY MarketBeat

Bristol Myers Squibb: Strong Pipeline, Weak Outlook (Rating Downgrade) - Seeking Alpha

Fri, 24 Apr 2026 07:00:00 GMT

Bristol Myers Squibb: Strong Pipeline, Weak Outlook (Rating Downgrade) Seeking Alpha

Science Firsthand: Translating the promise of cell therapy - Bristol Myers Squibb

Wed, 28 Jan 2026 08:00:00 GMT

Science Firsthand: Translating the promise of cell therapy Bristol Myers Squibb

Building a healthier future together: Strengthening cancer care across Africa through partnership - Bristol Myers Squibb

Tue, 16 Dec 2025 08:00:00 GMT

Building a healthier future together: Strengthening cancer care across Africa through partnership Bristol Myers Squibb

Bristol Myers Squibb files WARN notice for 206 jobs - ROI-NJ

Wed, 22 Apr 2026 07:00:00 GMT

Bristol Myers Squibb files WARN notice for 206 jobs ROI-NJ

Bristol-Myers Squibb Resets Pipeline With RNA Deals And Cost Focus - Yahoo Finance

Fri, 13 Feb 2026 08:00:00 GMT

Bristol-Myers Squibb Resets Pipeline With RNA Deals And Cost Focus Yahoo Finance

Karen Costello appointed General Manager of Bristol Myers Squibb Benelux - Bristol Myers Squibb

Mon, 30 Mar 2026 07:00:00 GMT

Karen Costello appointed General Manager of Bristol Myers Squibb Benelux Bristol Myers Squibb

BMS-Hengrui Pact Highlights China’s Rising Role in Drug Development - PharmTech.com

Tue, 12 May 2026 12:55:32 GMT

BMS-Hengrui Pact Highlights China’s Rising Role in Drug Development PharmTech.com

Water stewardship for environmental sustainability - Bristol Myers Squibb

Thu, 04 Dec 2025 08:00:00 GMT

Water stewardship for environmental sustainability Bristol Myers Squibb

Bristol Myers joins Hengrui party in 13-asset deal worth up to $15.2B - Endpoints News

Tue, 12 May 2026 09:06:00 GMT

Bristol Myers joins Hengrui party in 13-asset deal worth up to $15.2B Endpoints News

Bristol Myers Squibb honoured with the prestigious Prix Galien Award - Bristol Myers Squibb

Wed, 11 Feb 2026 08:00:00 GMT

Bristol Myers Squibb honoured with the prestigious Prix Galien Award Bristol Myers Squibb

Bringing life-saving medicines to more patients: Our commitment to low- and middle-income countries - Bristol Myers Squibb

Fri, 19 Dec 2025 08:00:00 GMT

Bringing life-saving medicines to more patients: Our commitment to low- and middle-income countries Bristol Myers Squibb

Human connections driving innovation & impact at GPS - Bristol Myers Squibb

Wed, 08 Oct 2025 07:00:00 GMT

Human connections driving innovation & impact at GPS Bristol Myers Squibb

Tempus Expands Strategic Collaboration with Bristol Myers Squibb to Enhance the Probability of Success Across Clinical Development Programs In Oncology and Neuroscience - The Joplin Globe

Thu, 14 May 2026 12:30:27 GMT

Tempus Expands Strategic Collaboration with Bristol Myers Squibb to Enhance the Probability of Success Across Clinical Development Programs In Oncology and Neuroscience The Joplin Globe

This pharma giant just announced hundreds more layoffs in N.J. - NJ.com

Tue, 21 Apr 2026 07:00:00 GMT

This pharma giant just announced hundreds more layoffs in N.J. NJ.com

Earnings call transcript: Bristol Myers Squibb Q1 2026 earnings beat expectations - Investing.com

Thu, 30 Apr 2026 07:00:00 GMT

Earnings call transcript: Bristol Myers Squibb Q1 2026 earnings beat expectations Investing.com

Addressing disparities and innovation in multiple myeloma - Bristol Myers Squibb

Thu, 05 Mar 2026 08:00:00 GMT

Addressing disparities and innovation in multiple myeloma Bristol Myers Squibb

Bristol Myers Squibb’s Breyanzi Approved by the U.S. FDA as the First and Only CAR T Cell Therapy for Adults with Relapsed or Refractory Marginal Zone Lymphoma (MZL) - Bristol Myers Squibb

Thu, 04 Dec 2025 08:00:00 GMT

Bristol Myers Squibb’s Breyanzi Approved by the U.S. FDA as the First and Only CAR T Cell Therapy for Adults with Relapsed or Refractory Marginal Zone Lymphoma (MZL) Bristol Myers Squibb

Bristol-Myers Inks Up to $15 Billion Licensing Deal With Hengrui - Bloomberg.com

Tue, 12 May 2026 06:38:00 GMT

Bristol-Myers Inks Up to $15 Billion Licensing Deal With Hengrui Bloomberg.com

Bristol Myers Squibb and Hengrui Pharma Partner to Develop 13 Oncology and Immunology Assets in $15 Billion Deal - geneonline.com

Tue, 12 May 2026 13:39:31 GMT

Bristol Myers Squibb and Hengrui Pharma Partner to Develop 13 Oncology and Immunology Assets in $15 Billion Deal geneonline.com

Bristol-Myers Squibb (BMY) Faces Stock Decline Despite Strong Q1 2026 Earnings - GuruFocus

Mon, 11 May 2026 21:47:29 GMT

Bristol-Myers Squibb (BMY) Faces Stock Decline Despite Strong Q1 2026 Earnings GuruFocus

Empowering patients with clarity & confidence through UPL program - Bristol Myers Squibb

Tue, 04 Nov 2025 08:00:00 GMT

Empowering patients with clarity & confidence through UPL program Bristol Myers Squibb

Bristol Myers Squibb AI Trials And 2026 Readouts Reframe Valuation - Yahoo Finance

Mon, 09 Feb 2026 08:00:00 GMT

Bristol Myers Squibb AI Trials And 2026 Readouts Reframe Valuation Yahoo Finance

Syngene International extends long-term research collaboration with Bristol Myers Squibb until 2035 - PR Newswire

Tue, 20 Jan 2026 08:00:00 GMT

Syngene International extends long-term research collaboration with Bristol Myers Squibb until 2035 PR Newswire